Radiopharmaceuticals

Radiopharmaceuticals are drugs that contain radioactive substances and are used in nuclear medicine for imaging, therapy, or both. Some are designed mainly to show how tissues function; others deliver therapeutic radiation to a targeted biological pathway. This means they occupy a unique space between diagnosis and treatment. ^[1][2][3]

What is a radiopharmaceutical?

A radiopharmaceutical combines a radioactive component with a molecule that helps direct it to a tissue, receptor, or metabolic pathway of interest. In diagnostic use, the goal is usually to create images that reflect function or molecular activity. In therapeutic use, the aim is to deliver radiation in a more targeted way than conventional external beam therapy. ^[1][2][4]

What is the difference between diagnostic and therapeutic use?

Diagnostic radiopharmaceuticals are commonly used in PET or SPECT imaging to reveal where a tracer accumulates. Therapeutic radiopharmaceuticals, by contrast, are intended to damage or control disease through emitted radiation. The same biological target may sometimes be used for both imaging and therapy, which is part of the logic behind modern theranostics. ^[1][2][5]

In which cancers can they be used?

Use depends on the target and the disease. Examples include thyroid disease and cancer, neuroendocrine tumours, prostate cancer in selected settings, and bone-targeted symptomatic treatments. Not every cancer has an established radiopharmaceutical pathway, and access may depend on infrastructure, regulatory approval, and centre expertise. ^[1][2][6]

How are treatment and safety managed?

Safety management includes indication review, organ function assessment, radiation safety instructions, monitoring for side effects, and post-treatment precautions where relevant. Many patients understandably worry about whether they will “emit radiation.” The answer depends on the agent used, the dose, and whether the use is diagnostic or therapeutic. This is why counselling is specific to the product, not generic to all nuclear medicine. ^[1][2][4]

What are the side effects and limitations?

Side effects vary widely by agent and target organ. Some diagnostic studies cause very limited after-effects, while therapeutic radiopharmaceuticals may involve marrow suppression, salivary effects, nausea, dry mouth, fatigue, renal considerations, or organ-specific toxicities. The limitation to remember is that targeted does not mean harmless; it means the biological route of delivery is more selective than nonspecific exposure. ^[1][2][6]

What matters in follow-up and when should a doctor be contacted?

Follow-up depends on whether the agent was diagnostic or therapeutic. For therapeutic use, imaging response, symptoms, blood counts, renal function, and organ-specific monitoring may be needed. Patients should promptly report fever, significant fatigue out of proportion to expectation, bleeding, severe nausea, or other symptoms highlighted in their treatment-specific instructions. ^[1][2]

Why is the theranostic approach so important?

Theranostics links diagnosis and therapy through the same or a related target. In practical terms, an imaging study may first show whether the target is present in a way that makes treatment likely to work. That can make treatment selection more biologically informed. ^[1][2][5]

In which patients is more caution needed?

Pregnancy, breastfeeding, reduced renal function, marrow vulnerability, prior heavy treatment exposure, and difficulties following radiation-safety instructions may all require extra consideration. ^[1][2][4]

What do diagnostic uses offer from the patient perspective?

They may provide information that standard anatomical imaging cannot fully show—for example, receptor expression, metabolic activity, or the distribution of disease. This can help refine diagnosis, staging, and treatment planning. ^[1][2][5]

What should patients ask during access and decision-making?

Useful questions include: What is the goal of this radiopharmaceutical—diagnosis or treatment? What side effects are expected? What precautions apply afterward? How will benefit be measured? Are there alternatives if this option is not available? ^[1][2]